Lastest pharma report "In Vitro Diagnostics: World Market Outlook 2011-2021" published by Visiongain

June 14, 2011 - PRLog -- How will the in vitro diagnostics (IVD) market develop this decade? Our report shows you potential revenues to 2021, discussing opportunities and prospects. Through our research and analysis we aim to save you time and help in your decisions.

Our new study shows you potential revenues to 2021 for in vitro diagnostics at total world, submarket and national levels. What technologies and applications will expand that market? What effects will changes have? You will find predictions and answers.

In our report you will find revenue predictions for clinical chemistry, immunochemistry, haematology, microbiological culture, genetic testing, immunotechnology, point of care testing (POCT) and laboratory testing.

You will find coverage of Roche, Siemens, Abbott Laboratories, Beckman Coulter and Becton, Dickinson and Company. We also discuss Quest Diagnostics, Laboratory Corporation of America and other companies in the medical diagnostics market.

Our study predicts future trends. You will find analyses of IVD applications in diabetes, oncology, infectious diseases, cardiovascular disorders, drug abuse and fertility testing.

We help you to assess the in vitro diagnostics industry and market’s strengths, weaknesses, trends and potential revenues to 2021. You will see where those technologies are heading.

Our new report provides data, analysis and opinion to benefit your research, calculations, meetings and presentations. To get that information please respond now.

Original analysis with revenues, growth rates, market shares, opinion and discussions
You will find revenue forecasts, growth rates, market shares, a SWOT/STEP review, opinions from our survey and discussions of technologies and companies. We provide 98 tables and charts and two research interviews (shown in the accompanying lists).

In Vitro Diagnostics: World Market Outlook 2011-2021 shows you opportunities, challenges and revenue forecasts
Our report gives you the following advantages:

• You will discover revenue forecasts to 2021 for the world in vitro diagnostics market and its main components, seeing where the highest revenue growth will occur
• You will find revenue forecasts to 2021 for IVD technologies, assessing their commercial potential and applications
• You will discover revenue forecasts to 2021 for leading national markets (US, Japan, Germany, France, Spain, UK, Italy, China and India), seeing growth trends
• You will assess leading companies in IVD, discovering their activities and outlooks
• You will investigate competition and opportunities influencing the IVD industry and market from 2011 onwards
• You will see what will stimulate and restrain the IVD industry and market from 2011
• You will identify diagnostic needs and commercial opportunities, including those for personalised medicine
• You will examine emerging medical diagnostic technologies, including theranostics, seeing opportunities and revenue potential
• You will analyse opportunities and challenges for established companies and those seeking to enter the IVD and personalised medicine market
• You will view opinions from our industry survey, receiving full interview transcripts.

That mix of quantitative and qualitative analysis sets our report apart. We tackle crucial questions in the in vitro diagnostics industry and market, aiming to save you time and effort.

Order our report now to gain industry and market analysis for medical diagnostic tests
Our report is for everybody interested in market analysis, product development, sales and marketing for diagnostic tests and devices. You will find predictions and answers. Don’t miss out – please order our report now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

For more details
Contact Person:
Bijal Patel
bijal.patel@visiongainglobal.com
0044(0)207 549 9946

# # #

Visiongain is an independent business information provider for the Telecoms, Pharmaceutical and Defence industries. We organise conferences, publish reports and newsletters, and provide consultancy services.